About Somatico
Somatico is a Healthcare company based in India founded in 1981. Pharmaceutical manufacturing and sales in therapy areas like respiratory and pain management in India. The company has 176 employees. Its Indian entity Somatico Pharmacal Private Limited reported revenue of ₹22.34 Cr. Somatico offers products and services including Respiratory Medicines and Pain Management Drugs. Its focus areas include Pharmaceuticals, Drug Manufacturing, Therapeutic Medicines and Research and Development.
Company details
Somatico Pharmacal is recognized for its development of patient-friendly medicines across various therapy areas, including respiratory care, pain management, dermatology, womens nutrition, and pediatric formulations. Innovations have been pioneered in the Indian pharmaceutical market, with a strong emphasis on research, development, and manufacturing processes. The company is noted for building inclusive teams and promoting internal growth, while products are distributed to the medical community through a dedicated sales force. It is based in Navi Mumbai, India, focusing on quality and therapeutic efficacy.
- Headquarters India
- Employees 176
- SectorsHealthcare
- Email••••••••
- Website somaticopharmacal.com
- Legal Name Somatico Pharmacal Pvt Ltd
- Date of Incorporation 20 Aug, 1977
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹22.34 Cr
FY 2025 · 0% YoY
- Net Profit₹45.8 Lakh
FY 2025 · 2% margin
- EBITDA₹67.2 Lakh
FY 2025 · 3% margin
- Employee Count176
Associated legal entities of Somatico
Somatico operates through Somatico Pharmacal Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Somatico Pharmacal Private Limited CIN U24230MH1977PTC019812 | Active | 20 Aug 1977 | Navi Mumbai, Maharashtra | ₹22.3 Cr | 176 | 3 | View details |
Products & Services of Somatico
Somatico offers a comprehensive portfolio of products and services, including Respiratory Medicines and Pain Management Drugs.
Medicines are developed for respiratory conditions, offering therapeutic rationale and quality.
Formulations are created for pain management, ensuring patient-friendly attributes.
Board of directors of Somatico Pharmacal Private Limited (Somatico)
Somatico Pharmacal Private Limited is the primary company behind Somatico. The board of Somatico Pharmacal Private Limited currently have 2 directors; the longest-serving is Samita Harish Chandrashekar Aiyer, appointed in 1979. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Samita Harish Chandrashekar Aiyer DIN 00446178 | Director | 01 Sep 1979 | 47 yrs 2 mo | Somatico Pharmacal Private Limited |
| Dipali Amey Rao DIN 03098363 | Director | 09 Jan 2019 | 7 yrs 9 mo | Somatico Pharmacal Private Limited |
Financials of Somatico
Figures of Somatico Pharmacal Private Limited, the primary company behind Somatico, for FY 2025. Revenue was ₹22.34 Cr (0% year on year). Net profit was ₹45.8 Lakh (2% margin). EBITDA was ₹67.2 Lakh (3% margin). Revenue has grown at a compounded annual rate of +11% over three years and +7% over five years.
- ₹22.34 CrRevenue · FY 2025 · 0% YoY
- ₹45.8 LakhNet profit · 2% margin
- ₹67.2 LakhEBITDA · 3% margin
- ₹16 LakhPaid-up capital
- 176Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Somatico Pharmacal Private Limited are on its company page.
Detailed financial statements for Somatico
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Somatico
Somatico was founded in 1981.
Somatico is headquartered in India.
Somatico has 176 employees.
The primary company behind Somatico, Somatico Pharmacal Private Limited, reported revenue of ₹22.34 Cr for FY 2025, down 0% year on year.
Somatico Pharmacal is recognized for its development of patient-friendly medicines across various therapy areas, including respiratory care, pain management, dermatology, womens nutrition, and pediatric formulations. Innovations have been pioneered in the Indian pharmaceutical market, with a strong emphasis on research, development, and manufacturing processes. The company is noted for building inclusive teams and promoting internal growth, while products are distributed to the medical community through a dedicated sales force. It is based in Navi Mumbai, India, focusing on quality and therapeutic efficacy.
Somatico offers Respiratory Medicines and Pain Management Drugs.
Somatico operates through Somatico Pharmacal Private Limited.
The legal entities of Somatico currently have 3 directors, including Avinash Subbanna Shetty, Samita Harish Chandrashekar Aiyer, Dipali Amey Rao.